Clinical Trials Directory

Trials / Completed

CompletedNCT04233762

Effect of Sex Hormone During the Menstrual Cycle on Capsaicin Evoked Cough Responses

The Effect of Sex Hormone Levels During the Menstrual Cycle on Capsaicin Evoked Cough

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The study aim is to investigate if changes in sex hormones during the menstrual cycle affects cough sensitivity in females and males with mild allergic asthma. Female subjects will be grouped according to natural cycle, or taking oral contraceptives. Male subjects will act as the control group.

Detailed description

The study will have a total of 3 visits separated by at least 24 hours. Screening Period (Visits 1) - For All Subjects. Eligible subjects will be identified during the initial screening procedures with measures of spirometry, hyperresponsiveness to methacholine, complete history, physical examination, allergen skin test, and capsaicin cough challenge. For female subjects, this visit will occur during Day 1-5 (follicular phase) of the menstrual cycle. Subjects meeting the eligibility criteria will be randomized to Sequence A or Sequence B. Sequence A will require Visit 2 to occur during menstrual cycle days 1-5 (follicular phase) and Visit 3 to occur during menstrual cycle days 21 - 25 (luteal phase). Sequence B will require Visit 2 to occur during menstrual cycle days 21-25 (luteal phase) and Visit 3 to occur during menstrual cycle days 1 - 5 (follicular phase). During Visit 2 and 3 subjects will undergo measures of spirometry, hyperresponsiveness to methacholine, capsaicin cough challenge, allergen skin test, sputum and blood collection. Visit Windows Each visit must be separated by a minimum of 24 hours. Study visits can be performed in the morning or afternoon, however for each subject the timing should be consistent with Visit 1 at the same time of day ± 2 hours.

Conditions

Timeline

Start date
2020-01-08
Primary completion
2022-05-30
Completion
2022-05-30
First posted
2020-01-18
Last updated
2024-03-01

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04233762. Inclusion in this directory is not an endorsement.